Literature DB >> 11518793

Adynamic renal osteodystrophy: is there a problem?

Isidro B Salusky1, William G Goodman1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11518793     DOI： 10.1681/ASN.V1291978

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  12 in total

Review 1.  Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.

Authors:  Uwe Querfeld; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-06-22       Impact factor: 3.714

Review 2.  Are new vitamin D analogues in renal bone disease superior to calcitriol?

Authors:  Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2005-02-03       Impact factor: 3.714

Review 3.  The role of bone biopsy in patients with chronic renal failure.

Authors:  Paul D Miller
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

4.  Middle-term use of Cinacalcet in paediatric dialysis patients.

Authors:  Caroline Platt; Carol Inward; Mary McGraw; Jan Dudley; Jane Tizard; Christine Burren; Moin A Saleem
Journal:  Pediatr Nephrol       Date:  2009-10-17       Impact factor: 3.714

Review 5.  Bone health and vascular calcification relationships in chronic kidney disease.

Authors:  Goce B Spasovski
Journal:  Int Urol Nephrol       Date:  2007-09-26       Impact factor: 2.370

Review 6.  New PTH assays and renal osteodystrophy.

Authors:  Isidro B Salusky; Harald Jüppner
Journal:  Pediatr Nephrol       Date:  2004-05-15       Impact factor: 3.714

7.  Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.

Authors:  Michael Freundlich; Michael Jofe; William G Goodman; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

8.  Sevelamer hydrochloride: an effective phosphate binder in dialyzed children.

Authors:  Homa Mahdavi; Beatriz D Kuizon; Barbara Gales; He-Jing Wang; Robert M Elashoff; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2003-10-30       Impact factor: 3.714

9.  Bone histomorphometry after treatment with teriparatide (PTH 1-34) in a patient with adynamic bone disease subsequent to parathyroidectomy.

Authors:  Gabriele Lehmann; Undine Ott; Jörg Maiwald; Gunter Wolf
Journal:  NDT Plus       Date:  2008-11-12

10.  (18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.

Authors:  Michelle L Frost; Juliet E Compston; David Goldsmith; Amelia E Moore; Glen M Blake; Musib Siddique; Linda Skingle; Ignac Fogelman
Journal:  Calcif Tissue Int       Date:  2013-08-31       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.